Atherosclerosis is a complex disease that starts during childhood and becomes clinically evident later in life. Atherosclerosis results from an interaction between diverse factors including lipid metabolism, blood coagulation elements, cytokines and hemodynamic stress. Humoral and cellular immune reactions are key events in pathogenesis with the balance between proinflammatory and anti-inflammatory stimuli being crucial for the development of atherosclerotic lesions. Atherosclerotic lesions are characterised by the presence of immune competent cells including T-cells and dendritic cells. Dendritic cell interactions with T-cells might be responsible for T-cell activation in atherogenesis. Despite increasing acknowledgment that immune-inflammatory processes participate in atherogenesis. the immune mechanisms remain incompletely defined.
RossR.The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 1993, 362, 801–809.
2.
WatanabeT., HaraokaS. and ShimokamaT.Inflammatory and immunological nature of atherosclerosis. International Journal of Cardiology, 1996, 54, S51–S60(Suppl.).
3.
HanssonG. K.Immune and inflammatory mechanisms in the development of atherosclerosis. British Heart Journal, 1993, 69, S38–S41(Suppl.).
4.
LibbyP. and HanssonG. K.Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Laboratory Investigation, 1991, 64, 5–15.
5.
WickG.SchettG.AmbergerA.KleindienstR.XuQ.Is atherosclerosis an immunologically mediated disease?Immunology Today, 1995, 16, 27–33.
6.
KumeN., CybulskyM. I. and GimbroneM. A.Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. Journal of Clinical Investigation, 1992, 90, 1138–1144.
7.
McMurrayH. F., ParthasarathyS. and SteinbergD.Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. Journal of Clinical Investigation, 1993, 92, 1004–1008.
BrownM. S. and GoldsteinJ. L.A receptor-mediated pathway for cholesterol homeostasis. Science, 1986, 232, 34–47.
10.
GoldsteinJ. L.HoY. K.BasuS. K.BrownM. S.Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoproteins, producing massive cholesterol depositions. Proceedings of the National Academy of Sciences USA, 1979, 76, 333–337.
11.
SeifertP. S. and HanssonG. K.Complement receptors and regulatory proteins in human atherosclerotic lesions. Arteriosclerosis, 1989, 9, 802–811.
12.
SalonenJ. T., Yla-HerttualaS., YamamotoR.Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet, 1992, 339, 883–887.
13.
XuQ., DietrichH., SteinerH. J.Induction of atherosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arteriosclerisclerosis and Thrombosis, 1992, 12, 789–799.
14.
AdamE., MelnickJ. L., ProbtsfieldJ. L.High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet, 1987, 2, 291–293.
15.
YamashiroyaH. M.GhoshL.YangR.RobertsonA. L.Herpesviridae in the coronary arteries and aorta of young trauma victims. American Journal of Pathology, 1988, 130, 71–79.
16.
MuhlesteinJ. B., HammondE. H., CarlquistJ. F.Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. Journal of American College of Cardiology, 1996, 27, 1555–1561.
17.
XuQ. B.OberhuberG.GruschwitzM.WickG.Immunology of atherosclerosis: cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens. Clinical Immunology and Immunopathology, 1990, 56, 344–359.
18.
SohmaY.SasanoH.ShigaR.SaekiS.SuzukiT.NaguraH.NoseN.Accumulation of plasma cells in atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits. Proceedings of the National Academy of Sciences USA, 1995, 92, 4937–4941.
19.
JonassonL.HolmJ.ScalliO.BondjersG.HanssonG. K.Regional accumulation of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Atherosclerosis, 1986, 6, 131–138.
20.
GownA. M., TsukadaT. and RossR.Human atherosclerosis II, immunocytochemical analysis of the cellular composition of atherosclerotic lesions. American Journal of Pathology, 1986, 125, 191–207.
21.
EmesonE. E. and RobertsonA. L.T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis. American Journal of Pathology, 1988, 130, 369–376.
22.
HanssonG. K.JonassonL.LojsthedB.StemmeS.KocherO.GabbianiG.Localization of T-lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaques. Arteriosclerosis, 1988, 72, 135–141.
23.
HanssonG., HolmJ. and JonassonL.Detection of activated T lymphocytes in the human atherosclerotic plaque. American Journal of Pathology, 1989, 135, 169–175.
24.
StemmeS. and HanssonG. K.Immune mechanisms in atherosclerosis. Coronary Artery Disease, 1994, 5, 216–222.
25.
FrostegårdJ.WuR.GiscombeR.HolmG.LefvertA. K.NilssonJ.Induction of T-cell activation by oxidized low density lipoprotein. Arteriosclerosis and Thrombosis, 1992, 12, 461–467.
26.
StemmeS.FaberB.HolmJ.WiklundO.WitztumJ. L.HanssonG. K.T lymphocytes from human atherosclerotic plaques recognize oxidized LDL. Proceedings of the National Academy of Sciences USA, 1995, 92, 3893–3897.
27.
StemmeS., HolmJ. and HanssonG. K.T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arteriosclerosis and Thrombosis, 1992, 12, 206–211.
28.
SwansonS. J.RosenzweigA.SeidmanJ. G.LibbyP.Diversity of T-cell antigen receptor V gene utilization in advanced human atheroma. Arteriosclerosis and Thrombosis, 1994, 14, 1210–1214.
29.
RomagnaniS.Lymphokine production by human T cells in disease states. Annual Review of Immunology, 1994, 12, 227–257.
30.
SederR. A. and PaulW. E.Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annual Review of Immunology, 1994, 12, 635–673.
31.
FrostegardJ.UlfgrenA. K.NybergP.HedinU.SwedenborgJ.AnderssonU.HanssonG. K.Cytokine expression in advanced human atherosclerotic plaques: dominance of proinflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis, 1999, 145, 33–43.
32.
SederR. A.GazzinelliR.SherA.PaulW. E.Interleukin 12 acts durectly on CD4+ T cells to enhance priming for interferon-production and diminishes interleukin-4 inhibition of such priming. Proceedings of the National Academy of Sciences USA, 1993, 90, 10188–10192.
33.
HsiehC.MacatoniaS. E.TrippC. S.WolfS. F.O'GarraA.MurphyK. M.Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science, 1993, 260, 547–549.
34.
D'AndreaA.Aste-AmezagaM.ValianteN. M.MaX.KubinM.TrinchieriG.Interleukin 10 (IL-10) inhibits human lymphocyte interferon-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. Journal of Experimental Medicine, 1993, 178, 1041–1048.
35.
HanssonG. K., HolmJ. and JonassonL.Detection of activated T lymphocytes in the human atherosclerotic plaque. American Journal of Pathology, 1989, 135, 169–175.
36.
GengY. J.HolmJ.NygrenS.BruzeliusM.StemmeS.HanssonG. K.Expression of macrophage scavenger receptor in atherosclerosis. Relationship between scavenger receptor isoforms and the T cell cytokine, interferon-. Arteriosclerosis, Thrombosis and Vascular Biology, 1995, 15, 1095–1202.
37.
UyemuraK., DemerL., CastleS. C.Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. Journal of Clinical Investigation, 1996, 97, 2130–2138.
38.
Ylä-HerttualaS., PalinskiW., RosenfeldM. E.Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. Journal of Clinical Investigation, 1989, 84, 1086–1095.
39.
XuQ.KleindienstR.WaitzW.DietrichH.WickG.Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65. Journal of Clinical Investigation, 1993, 91, 2693–2702.
40.
HuangY. J., RonnelidJ. and FrostegårdJ.Oxidized LDL induces enhanced antibody formation and MHC class II-depen-dent interferon-production in lymphocytes from healthy individuals. Arteriosclosis, Thrombosis and Vascular Biology, 1995, 15, 1577–1583.
41.
FrostegårdJ.KjellmanB.GidlundM.AnderssonBJindalS.KiesslingR.Induction of heat shock protein in monocytic cells by oxidized low density lipoprotein. Atherosclerosis, 1996, 121, 93–103.
42.
GengY.-J. and HanssonG. K.High endothelial cells of postcapillary venules express thescavenger receptor in human peripheral lymph nodes. Scandinavian Journal of Immunology, 1995, 42, 289–296.
43.
BobryshevY. V. and LordR. S. A.Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of vascular dendritic cells in athero resistant and athero-prone areas of the normal aorta. Archives of Histology and Cytology, 1995, 58, 307–322.
44.
BobryshevY. V.LordR. S. A.RainerSJamalO. S.MunroV. F.Vascular dendritic cells and atherosclerosis. Pathology, Research and Practice, 1992, 192, 462–467.
45.
BobryshevY. V. and LordR. S. A.Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions. Cardiovascular Research, 1998, 37, 799–810.
46.
BobryshevY. V. and LordR. S. A.Structural heterogeneity and contacting interactions of vascular dendritic cells in early atherosclerotic lesions of the human aorta. Journal of Submicroscopic Cytology and Pathology, 1996, 28, 49–60.
47.
SteinmanR. M.The dendritic cell system and its role in immunogenicity. Annual Review of Immunology, 1991, 9, 271–296.
48.
KingP. D. and KatzD. R.Mechanisms of dendritic cell function. Immunology Today, 1990, 11, 206–211.
49.
SprecherE. and BeckerY.Role of Langerhans cells and other dendritic cells in disease states. In vivo, 1993, 7, 217–227.
50.
BanchereauJ. and SteinmanR. M.Dendritic cells and the control of immunity. Nature, 1998, 392, 245–252.
51.
SteinmanR. M. and CohnZ. A.Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. Journal of Experimental Medicine, 1973, 137, 1142–1148.
52.
HartD. N. and FabreJ. W.Major histocompatibility complex antigens in rat kidney, ureter, and bladder. Localisation with monoclonal antibodies and demonstration of Ia-positive dendritic cells. Transplantation, 1981, 31, 318–325.
53.
HartD. N.Dendritic cells: unique leucocyte populations which control the primary immune response. Blood, 1997, 90, 3245–3287.
54.
BobryshevY. V., LordR. S. A. and WatanabeT.Structural peculiarities of vascular dendritic cell tubulovesicular system in human atherosclerotic aorta. Journal of Submicroscopic Cytology and Pathology, 1997, 29, 553–561.
55.
PureE., InabaK., CrowleyM. T.Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of MHC class II molecules and expression of invariant chain. Journal of Experimental Medicine, 1990, 172, 1459–1469.
56.
InabaK.MetlayJ. P.CrowleyM. T.SteinmanR. M.Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T-cells in situ. Journal of Experimental Medicine, 1990, 172, 631–640.
57.
KnightS. C.KrejciJ.MalkovskyM.ColizziV.GautumA.AshersonG. L.The role of dendritic cells in the initiation of immune responses to contact sensitizers. In vivo exposure to antigen. Cellular Immunology, 1985, 94, 427–434.
58.
RomaniN. and SchulerG.The immunologic properties of epidermal Langerhans cells as part of the dendritic cell system. Springer Seminar of Immunopathology, 1992, 13, 256–279.
59.
WinzlerC., RovereP., RescignoM.Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. Journal of Experimental Medicine, 1997, 185, 317–328.
60.
SallustoF. and LanzavecchiaA.Dendritic cells use macropinocytosis and the mannose receptor to concentrate antigen to the MHC class II compartment. Down regulation by cytokines and bacterial products. Journal of Experimental Medicine, 1995, 182, 389–400.
61.
BuelensC.VerhasseltV.De GrooteD.ThielemansK.GoldmanM.WillemsF.Human dendritic cell responses to lipopolysaccharides and CD40 ligation are differentially regulated by IL-10. European Journal of Immunology, 1997, 27, 1848–1852.
ColacoC. A.Towards a unified theory of immunity: dendritic cells, stress proteins and antigen capture. Cellular and Molecular Biology, 1998, 44, 883–890.
64.
TheryC., RegnaultA. and GarinJ.Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. Journal of Cell Biology, 1999, 147, 599–610.
65.
NicchittaC. V.Role of chaperones in antigen processing. Immunology Investigation, 2000, 29, 101–104.
66.
BasuS. and SrivastavaP.Heat shock proteins: the fountainhead of innate and adaptive immune responses. Cell Stress Chaperones, 2000, 5, 443–451.
67.
BasuS.BinderR. J.RamalingamT.SrivastavaP. K.CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity, 2001, 14, 303–313.
68.
TodrykS., MelcherA. A., HardwickN.Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. Journal of Immunology, 1999, 163, 1398–1408.
69.
O'BrienK. D., AllenM. D., McDonaldT. O.Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques: implications for the mode of progression of advanced coronary atherosclerosis. Journal of Clinical Investigation, 1993, 92, 945–951.
70.
ZhangY.CliffW. J.SchoeflG. I.HigginsG.Immunohistochemical study of intimal microvessels in coronary atherosclerosis. American Journal of Pathology, 1993, 143, 164–172.
71.
O'BrienE. R.GarvinM. R.DevR.StewartD. K.HinoharaT.SimpsonJ. B.SchwartzS. M.Angiogenesis in human coronary atherosclerotic plaques. American Journal of Pathology, 1994, 145, 883–894.
72.
O'BrienK. D.McDonaldT. O.ChaitA.AllenM. D.AlpersC. E.Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation, 1996, 93, 672–682.
73.
BobryshevY. V.CherianS. M.InderS. J.LordR. S. A.Neovascular expression of VE-cadherin in human atherosclerotic arteries and its relation to intimal inflammation. Cardiovascular Research, 1999, 43, 1003–1017.
74.
BargerA. C.BeeuwkesR.LaineyL. L.SilvermanK. J.Hypothesis: vasa vasorum and neovascularization of human coronary arteries: a possible role in the pathophysiology of atherosclerosis. New England Journal of Medicine, 1984, 310, 175–177.
75.
KumamotoM., NakashimaY. and SueishiK.Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance. Human Pathology, 1995, 26, 450–456.
76.
BujaL. M. and WillersonJ. T.Role of inflammation in coronary plaque disruption. Circulation, 1994, 89, 503–505.
77.
de BoerO. J.van der WalA. C.TeelingP.BeckerA. E.Leukocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization?Cardiovascular Research, 1999, 41, 443–449.
78.
Van der WalA. C. and BeckerA. E.Atherosclerotic plaque rupture-pathologic basis of plaque stability and instability. Cardiovascular Research, 1999, 41, 334–344.
79.
CouffinhalT.KearneyM.WitzenbichlerB.ChenD.MuroharaT.LosordoD. W.SymesJ.IsnerJ. M.Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. American Journal of Pathology, 1997, 150, 1673–1685.
80.
InoueM., ItohH., UedaM.Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation, 1998, 98, 2108–2116.
81.
ChenY. X.NakashimaY.TanakaK.ShiraishiS.NakagawaK.SueishiK.Immunohistochemical expression of vascular endothelial growth factor/vascular permeability factor in atherosclerotic intimas of human coronary arteries. Arteriosclerosis, Thrombosis and Vascular Biology, 1999, 9, 131–139.
82.
KlagsbrunM. and D'AmoreP. A.Vascular endothelial growth factor and its receptors. Cytokine and Growth Factor Review, 1996, 7, 259–270.
83.
StephanC. C. and BrockT. A.Vascular endothelial growth factor, a multifunctional polypeptide. PR Health Science Journal, 1996, 15, 169–178.
84.
DvorakH. F.BrownL. F.DetmarM.DvorakA. M.Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. American Journal of Pathology, 1995, 146, 1029–1039.
85.
SengerD. R.ClaffeyK. P.BenesJ. E.PerruzziC. A.SergiouA. P.DetmarM.Angiogenesis promoted by vascular endothelial growth factor: regulation through 1ß1 integrins. Proceedings of the National Academy of Sciences USA, 1997, 94, 13612–13617.
86.
PepperM. S.FerraraN.OrciL.MontesanoR.Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochemical and Biophysical Research Communications, 1991, 181, 902–906.
87.
FerraraN. and Davis-SmythT.The biology of vascular endothelial growth factor. Endocrinology Review, 1997, 18, 4–25.
88.
ClaussM.WeichH.BreierG.KniesU.RocklW.WaltenbergerJ.RisauW.The vascular endothelial growth factor receptor Flt-1 mediates biological activities: implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. Journal of Biological Chemistry, 1996, 271, 17629–17634.
89.
BarleonB.SozzaniS.ZhouD.WeichH. A.MantovaniA.MarmeD.Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood, 1996, 87, 3336–3343.
90.
Colville-NashP. R. and WilloughbyD. A.Growth factors in angiogenesis: current interest and therapeutic potential. Molecular Medicine Today, 1997, 3, 14–23.
91.
BreierG.DamertA.PlateK. H.RisauW.Angiogenesis in embryos and ischemic diseases. Thrombosis and Haemostasis, 1997, 78, 678–683.
92.
ShalabyF.RossantJ.YamaguchiT. P.GertsensteinM.WuX. F.BreitmanM. L.SchuhA. C.Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature, 1995, 376, 62–66.
93.
HanahanD. and FolkmanJ.Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 1996, 86, 353–364.
94.
AppletonI.BrownN. J.WillisD.Colville-NashP. R.AlamC.BrownJ. R.WilloughbyD. A.The role of vascular endothelial growth factor in a murine chronic granulomatous tissue air pouch model of angiogenesis. Journal of Pathology, 1996, 180, 90–94.
95.
HataY.NakagawaK.IshibashiT.InomataH.UenoH.SueishiK.Hypoxia-induced expression of vascular endothelial growth factor by retinal glial cells promotes in vitro angiogenesis. Virchows Archives, 1995, 426, 479–486.
96.
ShweikiD.ItinA.SofferD.KeshetE.Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature, 1992, 359, 843–845.
97.
StavriG. T.ZacharyI. C.BaskervilleP. A.MartinJ. F.ErusalimskyJ. D.Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells: synergistic interaction with hypoxia. Circulation, 1995, 92, 11–14.
98.
StavriG. T.HongY.ZacharyI. C.BreierG.BaskervilleP. A.Yla-HerttualaS.RisauW.MartinJ. F.ErusalimskyJ. D.Hypoxia and platelet-derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells. FEBS Letters, 1995, 358, 311–315.
99.
PertovaaraL.KaipainenA.MustonenT.OrpanaA.FerraraN.SakselaO.AlitaloK.Vascular endothelial growth factor is induced in response to transforming growth factor-ß in fibroblastic and epithelial cells. Journal of Biological Chemistry, 1994, 269, 6271–6274.
100.
JacksonJ. R.MintonJ. A.HoM. L.WeiN.WinklerJ. D.Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1ß. Journal of Rheumatology, 1997, 24, 1253–1259.
101.
SilinsG.GrimmondS.EgertonM.HaywardN.Analysis of the promoter region of the human VEGF-related factor gene. Biochemical and Biophysical Research Communications, 1997, 230, 413–418.
102.
LiuY.CoxS. R.MoritaT.KourembanasS.Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells: identification of a 5′ enhancer. Circulation Research, 1995, 77, 638–643.
103.
MinchenkoA.SalcedaS.BauerT.CaroJ.Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell and Molecular Biology Research, 1994, 40, 35–39.
104.
DamertA., IkedaE. and RisauW.Activator-protein-1 binding potentiates the hypoxia-inducible factor-1-mediated hypoxia-induced transcriptional activation of vascular-endo-thelial growth factor expression in C6 glioma cells. Biochemical Journal, 1997, 327, 419–423.
105.
RyutoM.OnoM.IzumiH.YoshidaS.WeichH. A.KohnoK.KuwanoM.Induction of vascular endothelial growth factor by tumor necrosis factor-in human glioma cells: possible roles of SP-1. Journal of Biological Chemistry, 1996, 271, 28220–28228.
106.
BjornhedenT., EvaldssonM. and WiklundO.A method for the assessment of hypoxia in the arterial wall, with potential application in vivo. Arteriosclerosis, Thrombosis and Vascular Biology, 1996, 16, 178–185.
107.
WinternitzM. C., ThomasR. M. and LeCompteP. M.The Biology of Arteriosclerosis. Charles C. Thomas, Springfield, Illinois, 1938.
108.
BargerA. C.BeeuwkesR.LaineyL. L.SilvermanK. J.Hypothesis: vasa vasorum and neovascularization of human coronary arteries: a possible role in the pathophysiology of atherosclerosis. New England Journal of Medicine, 1984, 310, 175–177.
109.
ZhangY.CliffW. J.SchoeflG. I.HigginsG.Immunohistochemical study of intunal microvessels in coronary atherosclerosis. American Journal of Pathology, 1993, 143, 164–172.
110.
CybulskyM. I. and GimbroneM. A.Jr.Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science, 1991, 251, 788–791.
111.
PostonR. N.HaskardD. O.CoucherJ. R.GailN. P.Johnson-TideyR. R.Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. American Journal of Pathology, 1992, 140, 665–673.
112.
PrintsevaO. Y., PecloM. M. and GownA. M.Various cell types in human atherosclerotic lesions express ICAM-1: further immunocytochemical and immunohistochemical studies employing monoclonal antibody 10F3. American Journal of Pathology, 1992, 140, 889–896.
113.
Van der WalA. C.DasP. K.TiggesA. J.BeckerA. E.Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. American Journal of Pathology, 1992, 141, 1427–1433.
114.
JangY.LincoffA. M.PlowE. F.TopolE. J.Cell adhesion molecules in coronary artery disease. Journal of American College of Cardiology, 1994, 24, 1591–1601.
115.
BobryshevY. V.LordR. S. A.RainerS.MunroV. F.VCAM-1 expression and network of VCAM-1 positive vascular dendritic cells in advanced atherosclerotic lesions of carotid arteries and aortas. Acta Histochemistry, 1996, 98, 185–194.
116.
BrogiE.WinklesJ. A.UnderwoodR.ClintonS. K.AlbertsG. F.LibbyP.Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries: association of acidic FGF with plaque microvessels and macrophages. Journal of Clinical Investigation, 1993, 92, 2408–2418.
117.
AllportJ. R.DingH.CollinsT.GerritsenM. E.LuscinskasF. W.Endothelial-dependent mechanisms regulate leukocyte transmigration: a process involving the proteasome and disruption of the vascular endothelial-cadherin complex at endothelial cell-to-cell junctions. Journal of Experimental Medicine, 1997, 186, 517–527.
118.
Del MaschioA.ZanettiA.CoradaM.RivalY.RucoL.LampugnaniM. G.DejanaE.Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions. Journal of Cell Biology, 1996, 135, 497–510.
MullerW. A.WeiglS. A.DengX.PhillipsD. M.PECAM-1 is required for transendothelial migration of leukocytes. Journal of Experimental Medicine, 1993, 178, 449–460.
121.
RandolphG. J.BeaulieuS.LebecqueS.SteinmanR. M.MullerW. A.Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science, 1998, 282, 480–483.
122.
AnitchkowN. N.Vessels, Special Pathologic Anatomy, Vol. 2Medgiz, Moscow, 1947.
123.
HirotaS., ImakitaM., KohriK.Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques: a possible association with calcification. American Journal of Pathology, 1993, 143, 1003–1008.
124.
IkedaT.ShirasawaT.EsakiY.YoshikiS.HirokawaK.Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotoc lesions of the aorta. Journal of Clinical Investigation, 1993, 92, 2814–2820.
125.
BoströmK.WatsonK. E.HornS.WorthamC.HermanI. M.DemerL. L.Bone morphogenic protein expression in human atherosclerotic lesions. Journal of Clinical Investigation, 1993, 91, 1800–1809.
126.
WatsonK. E.BoströmK.RavindranathR.LamT.NortonB.DemerL. L.TGF-ß1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. Journal of Clinical Investigation, 1994, 93, 2106–2113.
127.
SchorA. M.AllenT. D.CanfieldA. E.SloanP.SchorS. L.Pericytes derived from the retinal microvasculature undergo calcification in vitro. Journal of Cell Science, 1990, 97, 449–461.
128.
TiltonD. G.Capillary pericytes: perspectives and future trends. Journal of Electron Microscopy, 1991, 19, 327–344.
129.
LanghaasT.Beitrage zur normalen und pathologischen Anatomie der Arterien. Virchotos Archives, 1866, 36, 187–226.
130.
OrekhovA. N., AndreevaE. R., KrushinskyA. V.Intimal cells and atherosclerosis. Relationship between the number of intimal cells and major manifestation of atherosclerosis in the human aorta. American Journal of Pathology, 1992, 125, 402–414.
131.
RekhterM. D.AndreevaE. R.AndrainovaI. V.MironovA. A.OrekhovA. N.Stellate cells of aortic intima: I. Human and rabbit. Tissue and Cell, 1992, 24, 689–696.
132.
RekhterM. D.AndreevaG. K.MironovA. A.OrekhovA. N.Three-dimensional cytoarchitecture of normal and atherosclerotic intima of human aorta. American Journal of Pathology, 1991, 138, 569–574.
133.
SchonfelderM.Ortologie und Pathologie der Langhans-Zellen der Aortenintima des Menschen. Pathologie und Microbiologie, 1969, 33, 129–145.
134.
BobryshevY. V. and LordR. S. A.Langhans cells of human arterial intima: uniform by stellate appearance but different by nature. Tissue and Cell, 1996, 28, 177–194.
135.
D'AmoreP. A.Culture and study of pericytes. In Cell Culture Techniques in Heart and Vessel Research, ed. PiperH. M.. Springer-Verlag, Berlin1990, pp. 299–314.
136.
Diaz-FloresL.ValladaresF.GutierrezR.VarelaH.The role of pericytes of the adventitial microcirculation in the arterial intimal thickening. Histology and Histopathology, 1990, 5, 145–153.
137.
HermanI. M. and D'AmoreP. A.Microvascular pericytes contain muscle and nonmuscle actins. Journal of Cell Biology, 1985, 10, 43–52.
138.
NayakR. C.BermanA. B.GeorgeK. L.EisenbarthG. S.KingG. L.A monoclonal antibody (3G5)-defined ganglioside antigen is expressed on the cell surface of microvascular pericytes. Journal of Experimental Medicine, 1988, 167, 1003–1015.
139.
BrightonC. T.LorichD. G.KupchaR.RiellyT. M.JonesA. R.WoodburyR. A.The pericyte as a possible osteoblast progenitor cell. Clinical Orthop Related Research, 1992, 275, 287–299.
140.
SchwartzS. M., HeimarkR. L. and MajeskyM. W.Developmental mechanisms underlying pathology of arteries. Physiology Review, 1990, 70, 1177–1209.
141.
SimsD. E.Recent advances in pericyte biology—implications for health and disease. Canadian Journal of Cardiology, 1991, 7, 431–443.
142.
SobolevaE.PopkovaV.SaburovaO.TararakE.SmirnovV. N.Circulating cells of bone marrow origin and atherosclerosis. Atherosclerosis, 1994, 109, 348.
143.
SobolevaE. L.SaburovaO. V.ProkophevaL. V.TararakE. M.SmirnovV. N.Stem cells in blood of patients with primary hypercholesterolemia. Atherosclerosis, 1995, 115, S60(Suppl.).
144.
AshtonB. A.EaglesomC. C.BabI.OwenM. E.Distribution of fibroblastic colony-forming cells in rabbit bone marrow and assay of their osteogenic potential by an in vivo diffusion chamber method. Calcified Tissue International, 1984, 36, 83–86.
145.
LuriaE. A.OwenM. E.FriedensteinA. J.MorrisJ. F.KuznetsovS. A.Bone formation in organ cultures of bone marrow. Cell and Tissue Research, 1978, 248, 449–454.
146.
JotereauF. W. and Le DouarinN. M.The developmental relationship between osteocytes and osteoblasts: a study using the quail-chick nucleus marker in endochondrial ossefication. Developmental Biology, 1978, 63, 253–265.
147.
AshP., LoutitJ. F. and TownsendK. M. S.Osteoclasts derived from haematopoietic stem cells. Nature, 1980, 283, 669–670.
148.
FishmanD. A. and HayE. D.Origin of osteoclasts from mononuclear leukocytes in regenerating new limbs. Anatomical Record, 1962, 143, 329–339.
149.
LongM. W., WilliamsJ. L. and MannK. G.Expression of bone-related proteins in the human hematopoietic mcroenvironment. Journal of Clinical Investigation, 1990, 86, 1387–1395.
150.
LongM. W.RobinsonJ. A.AshcraftE. A.MannK. G.Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors. Journal of Clinical Investigation, 1995, 95, 881–887.
